Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1952 2
1953 2
1954 1
1955 5
1956 4
1957 7
1958 3
1959 2
1960 7
1961 17
1962 21
1963 19
1964 25
1965 30
1966 27
1967 29
1968 28
1969 39
1970 33
1971 43
1972 58
1973 52
1974 60
1975 56
1976 41
1977 56
1978 82
1979 98
1980 99
1981 111
1982 140
1983 172
1984 146
1985 189
1986 184
1987 187
1988 197
1989 229
1990 224
1991 215
1992 266
1993 297
1994 293
1995 259
1996 319
1997 274
1998 338
1999 347
2000 373
2001 417
2002 395
2003 411
2004 426
2005 467
2006 543
2007 526
2008 515
2009 472
2010 541
2011 602
2012 659
2013 644
2014 644
2015 633
2016 609
2017 647
2018 688
2019 668
2020 769
2021 888
2022 817
2023 771
2024 339

Text availability

Article attribute

Article type

Publication date

Search Results

18,149 results

Results by year

Filters applied: . Clear all
Page 1
The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis.
Miyamoto K, Sujino T, Harada Y, Ashida H, Yoshimatsu Y, Yonemoto Y, Nemoto Y, Tomura M, Melhem H, Niess JH, Suzuki T, Suzuki T, Suzuki S, Koda Y, Okamoto R, Mikami Y, Teratani T, Tanaka KF, Yoshimura A, Sato T, Kanai T. Miyamoto K, et al. Among authors: tanaka kf. Cell Rep. 2023 Aug 29;42(8):113005. doi: 10.1016/j.celrep.2023.113005. Epub 2023 Aug 16. Cell Rep. 2023. PMID: 37590143 Free article.
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
Hayashi H, Chamoto K, Hatae R, Kurosaki T, Togashi Y, Fukuoka K, Goto M, Chiba Y, Tomida S, Ota T, Haratani K, Takahama T, Tanizaki J, Yoshida T, Iwasa T, Tanaka K, Takeda M, Hirano T, Yoshida H, Ozasa H, Sakamori Y, Sakai K, Higuchi K, Uga H, Suminaka C, Hirai T, Nishio K, Nakagawa K, Honjo T. Hayashi H, et al. Among authors: tanaka k. J Clin Invest. 2024 Apr 1;134(7):e168318. doi: 10.1172/JCI168318. J Clin Invest. 2024. PMID: 38557498 Free PMC article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: tanaka k. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Therapeutic potential for KCC2-targeted neurological diseases.
Tomita K, Kuwahara Y, Igarashi K, Kitanaka J, Kitanaka N, Takashi Y, Tanaka KI, Roudkenar MH, Roushandeh AM, Kurimasa A, Nishitani Y, Sato T. Tomita K, et al. Among authors: tanaka ki. Jpn Dent Sci Rev. 2023 Dec;59:431-438. doi: 10.1016/j.jdsr.2023.11.001. Epub 2023 Nov 11. Jpn Dent Sci Rev. 2023. PMID: 38022385 Free PMC article. Review.
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer.
Jänne PA, Planchard D, Kobayashi K, Cheng Y, Lee CK, Valdiviezo N, Laktionov K, Yang TY, Yu Y, Kato T, Jiang L, Chewaskulyong B, Lucien Geater S, Maurel JM, Rojas C, Takahashi T, Havel L, Shepherd FA, Tanaka K, Ghiorghiu D, Amin NP, Armenteros-Monterroso E, Huang X, Chaudhry AA, Yang JC. Jänne PA, et al. Among authors: tanaka k. J Clin Oncol. 2024 Mar 1;42(7):808-820. doi: 10.1200/JCO.23.02219. Epub 2023 Dec 2. J Clin Oncol. 2024. PMID: 38042525 Free PMC article. Clinical Trial.
Antimicrobial peptides modulate lung injury by altering the intestinal microbiota.
Abdelgawad A, Nicola T, Martin I, Halloran BA, Tanaka K, Adegboye CY, Jain P, Ren C, Lal CV, Ambalavanan N, O'Connell AE, Jilling T, Willis KA. Abdelgawad A, et al. Among authors: tanaka k. Microbiome. 2023 Oct 16;11(1):226. doi: 10.1186/s40168-023-01673-0. Microbiome. 2023. PMID: 37845716 Free PMC article.
Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia.
Abe Y, Yagishita S, Sano H, Sugiura Y, Dantsuji M, Suzuki T, Mochizuki A, Yoshimaru D, Hata J, Matsumoto M, Taira S, Takeuchi H, Okano H, Ohno N, Suematsu M, Inoue T, Nambu A, Watanabe M, Tanaka KF. Abe Y, et al. Among authors: tanaka kf. Cell Rep Med. 2023 Oct 17;4(10):101208. doi: 10.1016/j.xcrm.2023.101208. Epub 2023 Sep 28. Cell Rep Med. 2023. PMID: 37774703 Free PMC article.
Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.
Tanimizu H, Hara R, Sekine A, Inoue N, Hasegawa E, Tanaka K, Kono K, Kinowaki K, Ohashi K, Okubo M, Yamaguchi Y, Kang D, Honda K, Saito T, Sawa N, Ubara Y, Hoshino J. Tanimizu H, et al. Among authors: tanaka k. Intern Med. 2023;62(15):2209-2214. doi: 10.2169/internalmedicine.0834-22. Epub 2023 Aug 1. Intern Med. 2023. PMID: 37532513 Free PMC article.
Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T, Kunisada T, Nakata E, Nishida K, Yanai H, Nakamura T, Tanaka K, Ozaki T. Fujiwara T, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2023 Nov 5;53(11):1009-1018. doi: 10.1093/jjco/hyad102. Jpn J Clin Oncol. 2023. PMID: 37626447 Free PMC article. Review.
18,149 results
You have reached the last available page of results. Please see the User Guide for more information.